IFUSE IMPLANT SYSTEM
Report
- Report Number
- 3007700286-2012-00082
- Event Type
- Injury
- Date Received
- December 28, 2012
- Date of Event
- December 4, 2012
- Report Date
- December 28, 2012
- Manufacturer
- SIBONE
- Product Code
- OUR
- PMA / PMN Number
- K122074
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA, US
- Reporter Occupation
- PHYSICIAN
Narratives
PRODUCT WAS RETURNED FOR HISTOLOGY ANALYSIS BY HISTION (THIRD PARTY ANALYSIS LAB) TO ASSESS BONY IN-GROWTH. NO STRUCTURAL ANALYSIS IS PERFORMED. BASED UPON THE COMPLAINT INFORMATION AND INVESTIGATION, AS WELL AS REVIEW OF THE SURGEON TRAINING MANUAL, CERTIFICATE OF CONFORMANCE AND FMEA, THERE IS NO INDICATION OF DEVICE FAILURE OR THAT THE DEVICE WAS OUT OF SPECIFICATION. THE MOST PROBABLE ROOT CAUSE IS LATE SYMPTOMATIC LOOSENING.
THE SURGEON PERFORMED A RIGHT SI JOINT FUSION UTILIZING THREE IFUSE IMPLANTS ON (B)(6) 2012. PATIENT HAD GOOD PAIN RELIEF FOR 6 MONTHS AND THEN BEGAN TO DEVELOP PAIN SIMILAR TO HER PRE-OP PAIN. THE SURGEON BELIEVED THAT THERE WAS LUCENCY AROUND THE MIDDLE IMPLANT MEDIALLY AND PLANNED TO REMOVE THE MOST INFERIOR AND MIDDLE IMPLANT AND LEAVE THE SUPERIOR IMPLANT IN PLACE. HE PLANNED ON REPLACING THE IFUSE IMPLANTS WITH 2 GLOBUS SI-LOK 12 MM SCREWS. HE ATTEMPTED TO REMOVE THE MIDDLE IMPLANT USING OSTEOTOMES BUT WAS UNSUCCESSFUL IN MOVING THE IMPLANT BASED ON FLUORO. THE SURGEON DECIDED TO LEAVE IT IN PLACE. HE REMOVED THE INFERIOR IMPLANT WHICH LOOKED VOID OF BONY INGROWTH AND PLACED A 12 MM SI-LOK SCREW IN THE HOLE LEFT BY THE IMPLANT. MEDICAL ASSESSMENT BASED ON PLAIN FILMS SHOW WHAT DOES APPEAR FO BE SCLEROTIC LOOSENING OF THE SACRAL TIP OF THE IMPLANT. THE CT SCAN DOES NOT SHOW ANY EVIDENCE OF HALO ALONG ANY OF THE IMPLANTS. THIS APPEARS TO BE THE CASE OF SYMPTOMATIC LATE LOOSENING.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | IFUSE IMPLANT SYSTEM | PLATES, SCREWS, RODS | OUR | SIBONE |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 58 YR | Required Intervention |